267644-08-6

Basic information

• Product Name: (S)-N-(1-(2-(4-fluorophenyl)ethyl)pyrrolidin-3-yl)carbazole-9-carboxamide
• Synonyms: (S)-N-(1-(2-(4-fluorophenyl)ethyl)pyrrolidin-3-yl)carbazole-9-carboxamide
• CAS NO: 267644-08-6
• Molecular Weight: 401.483
• Mol File: 267644-08-6.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-N-(1-(2-(4-fluorophenyl)ethyl)pyrrolidin-3-yl)carbazole-9-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-N-(1-(2-(4-fluorophenyl)ethyl)pyrrolidin-3-yl)carbazole-9-carboxamide(267644-08-6)
• EPA Substance Registry System: (S)-N-(1-(2-(4-fluorophenyl)ethyl)pyrrolidin-3-yl)carbazole-9-carboxamide(267644-08-6)

Safety Data

• Hazardous Substances Data: 267644-08-6(Hazardous Substances Data)

Upstream product

• 267643-82-3 (s)-3-amino-1-(2-(4-fluorophenyl)ethyl)pyrrolidine 
• 73500-82-0 9-carbazole carbonyl chloride 

Relevant articles and documents

Pyrrolidine compounds and medicinal utilization thereof

The present invention provides a pyrrolidine compound of the formula (I) wherein each symbol is as defined in the specification, an optically active compound thereof and a pharmaceutically acceptable salt thereof. The present invention further provides a pharmaceutical composition containing a compound of the formula (I), an optically active compound thereof, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable additive. The compound of the present invention has a serotonin 2 receptor antagonistic action along with a platelet aggregation suppressive action, a peripheral circulation improving action and a lacrimation promoting action. Therefore, the compound of the present invention can be a useful medicine showing effect against thrombotic embolism, dry eye and the like.